CB-Exo-A600
/ Carrier Biomed
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 23, 2026
CB-EXOAD: The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
(clinicaltrials.gov)
- P1/2 | N=33 | Recruiting | Sponsor: Xuanwu Hospital, Beijing | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders
1 to 1
Of
1
Go to page
1